A pilot study: the efficacy of virgin coconut oil as ocular rewetting agent on rabbit eyes

Haliza Abdul Mutalib, Sharanjeet Kaur, Ahmad Rohi Ghazali, Ng Chinn Hooi, Nor Hasanah Safie, Haliza Abdul Mutalib, Sharanjeet Kaur, Ahmad Rohi Ghazali, Ng Chinn Hooi, Nor Hasanah Safie

Abstract

Purpose. An open-label pilot study of virgin coconut oil (VCO) was conducted to determine the safety of the agent as ocular rewetting eye drops on rabbits. Methods. Efficacy of the VCO was assessed by measuring NIBUT, anterior eye assessment, corneal staining, pH, and Schirmer value before instillation and at 30 min, 60 min, and two weeks after instillation. Friedman test was used to analyse any changes in all the measurable variables over the period of time. Results. Only conjunctival redness with instillation of saline agent showed significant difference over the period of time (P < 0.05). However, further statistical analysis had shown no significant difference at 30 min, 60 min, and two weeks compared to initial measurement (P > 0.05). There were no changes in the NIBUT, limbal redness, palpebral conjunctiva redness, corneal staining, pH, and Schirmer value over the period of time for each agent (P > 0.05). Conclusion. VCO acts as safe rewetting eye drops as it has shown no significant difference in the measurable parameter compared to commercial brand eye drops and saline. These study data suggest that VCO is safe to be used as ocular rewetting agent on human being.

Figures

Figure 1
Figure 1
Changes of NIBUT value for tested eye.

References

    1. Lemp M. A., Baudouin C., Baum J., et al. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international Dry Eye WorkShop (2007) Ocular Surface. 2007;5(2):75–92. doi: 10.1016/s1542-0124(12)70081-2.
    1. Mutalib H. A., Ghazali A. R., Ali N. S. Protein and microbial determination on worn contact lenses that were cleaned conventionally and using an automatic lens cleaner, Lens2. Malaysian Journal of Health Sciences. 2008;6(1):11–21.
    1. Mohd-Ali B., Fee L. S., Abdul-Mutalib H., Mohidin N. Incidence of dry eye in a sample population in Kuala Lumpur. International Journal of Collaborative Research on Internal Medicine & Public Health. 2011;3(11):839–845.
    1. Willen C. M., McGwin G., Liu B., Owsley C., Rosenstiel C. Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes. Eye and Contact Lens. 2008;34(1):43–45. doi: 10.1097/ICL.0b013e3180676d44.
    1. Uchiyama E., di Pascuale M. A., Butovich I. A., McCulley J. P. Impact on ocular surface evaporation of an artificial tear solution containing hydroxypropyl guar. Eye & Contact Lens. 2008;34(6):331–334. doi: 10.1097/icl.0b013e31818c66b5.
    1. Marina A. M., Man Y. B., Amin I. Virgin coconut oil: emerging functional food oil. Trends in Food Science & Technology. 2009;20(10):481–487. doi: 10.1016/j.tifs.2009.06.003.
    1. DeLuise V. P., Peterson W. S. The use of topical Healon tears in the management of refractory dry-eye syndrome. Annals of Ophthalmology. 1984;16(9):823–824.
    1. Mengher L. S., Pandher K. S., Bron A. J., Davey C. C. Effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes. British Journal of Ophthalmology. 1986;70(6):442–447. doi: 10.1136/bjo.70.6.442.
    1. Mengher L. S., Bron A. J., Tonge S. R., Gilbert D. J. Effect of fluorescein instillation on the pre-corneal tear film stability. Current Eye Research. 1985;4(1):9–12. doi: 10.3109/02713688508999961.
    1. Wei X. E., Markoulli M., Zhao Z., Willcox M. D. Tear film break-up time in rabbits. Clinical and Experimental Optometry. 2013;96(1):70–75. doi: 10.1111/j.1444-0938.2012.00801.x.
    1. El-Shazly A. H. M., El-Gohary A. A., El-Shazly L. H. M., El-Hossary G. G. Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits. Acta Pharmaceutica. 2008;58(2):163–173. doi: 10.2478/v10007-008-0009-0.
    1. Bron A. J., Evans V. E., Smith J. A. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640–650. doi: 10.1097/00003226-200310000-00008.
    1. Norn M. S. Micropunctate fluorescein vital staining of the cornea. Acta Ophthalmologica. 1970;48(1):108–118.
    1. Kikkawa Y. Normal corneal staining with fluorescein. Experimental Eye Research. 1972;14(1):13–14. doi: 10.1016/0014-4835(72)90137-6.
    1. Koc Y., Alkan F., Tepeli C. Schirmer tear test in different rabbit breeds. Journal of Animal Research. 2005;15(2):1–5.
    1. Lallemand F., Daull P., Benita S., Buggage R., Garrigue J. Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb. Journal of Drug Delivery. 2012;2012:16. doi: 10.1155/2012/604204.604204
    1. Coles W. H., Jaros P. A. Dynamics of ocular surface pH. British Journal of Ophthalmology. 1984;68(8):549–552. doi: 10.1136/bjo.68.8.549.
    1. López-Alemany A., Montés i Micó R. pH of multipurpose contact lens solutions over time. Contact Lens and Anterior Eye. 1998;21(1):7–10. doi: 10.1016/s1367-0484(98)80017-9.
    1. Ridder W. H., III, Lamotte J. O., Ngo L., Fermin J. Short-term effects of artificial tears on visual performance in normal subjects. Optometry & Vision Science. 2005;82(5):370–377. doi: 10.1097/01.opx.0000162646.30666.e3.
    1. Bron A. J. Diagnosis of dry eye. Survey of Ophthalmology. 2001;45(2):S221–S226. doi: 10.1016/S0039-6257(00)00201-0.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться